In addition to PC, RIPK2 is frequently amplified and/or overexpressed in several other cancer types (Supplementary Fig. 2), and its mRNA overexpression is associated with significantly shorter overall survival in nine cancer types (Supplementary Fig. 3). The gene discussed is RIPK2; the disease is pachyonychia congenita.